![Mark C. Clement](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mark C.
Clement is the founder of Celsis International Ltd. He served as the Director-Executive Board of Santhera Pharmaceuticals Holding AG from 2000 to 2006.
He was the Chief Executive Officer of Excalibur Fund Managers Ltd. in 2009 and Chairman of Alderley Analytical Ltd. He also served as a Non-Executive Director of De Novo Pharmaceuticals Ltd. Mr. Clement completed his undergraduate degree at the University of Birmingham.
Anciens postes connus de Mark C. Clement
| Sociétés | Poste | Fin |
|---|---|---|
Excalibur Fund Managers Ltd.
 Excalibur Fund Managers Ltd. Investment ManagersFinance Excalibur invests in companies located in the United Kingdom. The firm targets companies operating in the fields of biotechnology and medical devices. It provide financing for mezzanine, seed, early and later stage capital requirements. | President | 01/04/2010 |
| SANTHERA PHARMACEUTICALS HOLDING AG | Corporate Officer/Principal | 12/09/2006 |
Alderley Analytical Ltd.
 Alderley Analytical Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as an independent contract research organization focused on bioanalytical services | Président | - |
Celsis International Ltd.
 Celsis International Ltd. Medical SpecialtiesHealth Technology Develops and supplies medical diagnostic products and laboratory services | Fondateur | - |
De Novo Pharmaceuticals Ltd.
 De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Directeur/Membre du Conseil | - |
Formation de Mark C. Clement
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
15
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Celsis International Ltd.
Celsis International Ltd. Medical SpecialtiesHealth Technology Develops and supplies medical diagnostic products and laboratory services | Health Technology |
Excalibur Fund Managers Ltd.
Excalibur Fund Managers Ltd. Investment ManagersFinance Excalibur invests in companies located in the United Kingdom. The firm targets companies operating in the fields of biotechnology and medical devices. It provide financing for mezzanine, seed, early and later stage capital requirements. | Finance |
De Novo Pharmaceuticals Ltd.
De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Santhera Pharmaceuticals Holding AG
 Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
University of Birmingham
 University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alderley Analytical Ltd.
Alderley Analytical Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as an independent contract research organization focused on bioanalytical services | Commercial Services |
